Oral cancer inhibition by micronutrients. The experimental basis for clinical trials

Area of Science:

• Oncology
• Nutritional Science
• Cancer Prevention

Background:

• Oral cancer and precancerous leukoplakia pose significant health challenges.
• Micronutrients like retinoids, carotenoids, and tocopherol have demonstrated potential in preclinical studies.
• Understanding their mechanisms and synergistic effects is crucial for therapeutic development.

Purpose of the Study:

• To investigate the anticancer activity of retinoids, carotenoids, and tocopherol against oral cancer.
• To explore the role of these micronutrients in inhibiting carcinogenesis, preventing oral cancer, and regressing existing tumors.
• To examine potential synergistic interactions between these compounds and conventional chemotherapeutic agents.

Main Methods:

• Extensive animal model studies focusing on oral cancer inhibition, prevention, and regression.
• In vitro tissue culture studies utilizing animal and human oral cancer cell lines.
• Exploration of molecular mechanisms underlying the anticancer effects of these micronutrients.

Main Results:

• Retinoids, carotenoids, and tocopherol exhibit significant anticancer activity in experimental oral cancer models.
• Beta carotene and alpha tocopherol demonstrate synergistic anticancer effects.
• Beta carotene inhibits both initiation and promotion phases of carcinogenesis.
• Synergistic effects were also observed between beta carotene and alkylating agents (melphalan, cyclophosphamide).
• Studies confirmed these findings using both animal models and human oral cancer cell lines.

Conclusions:

• Micronutrients possess potent anticancer properties against oral cancer and precancerous lesions.
• Synergistic interactions enhance the efficacy of these compounds, potentially reducing the need for higher doses or combination with chemotherapy.
• Mechanisms involve immune system stimulation, enhanced heat-shock protein expression, and modulation of repressor genes like P53.